PW Medtech Logs Further Buy-Back; 4.52 Million Shares Repurchased to Date, Equal to 0.31% of Capital

Bulletin Express

Sep 11

PW Medtech Group Limited disclosed in its latest Next Day Disclosure Return that it repurchased an additional 106,000 ordinary shares on 11 September 2026 via on-market transactions at HKD 0.97–0.975 per share, for a total consideration of HKD 0.10 million.

Including this purchase, the company has acquired 4.52 million shares since activating its current repurchase mandate on 26 June 2026. The cumulative volume represents 0.31% of the 1.43 billion shares outstanding when the mandate was approved, while utilising roughly 3.13% of the 144.29 million-share authorisation.

All 4.52 million repurchased shares are awaiting cancellation; consequently, PW Medtech’s issued share capital remains unchanged at 1.43 billion shares as of 11 September 2026. Repurchase prices over the period have ranged from HKD 0.91 to HKD 1.10 per share.

Under Hong Kong Stock Exchange rules, PW Medtech is subject to a 30-day moratorium on issuing new shares following the latest buy-back, ending on 11 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1105675220"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105675220\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105675220?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-11 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105675220","market":"hk","top_or_hot":-1,"title":"PW Medtech Logs Further Buy-Back; 4.52 Million Shares Repurchased to Date, Equal to 0.31% of Capital","media":"Bulletin Express","content":"<p>PW Medtech Group Limited disclosed in its latest Next Day Disclosure Return that it repurchased an additional 106,000 ordinary shares on 11 September 2026 via on-market transactions at HKD 0.97–0.975 per share, for a total consideration of HKD 0.10 million.</p>\n<p>Including this purchase, the company has acquired 4.52 million shares since activating its current repurchase mandate on 26 June 2026. The cumulative volume represents 0.31% of the 1.43 billion shares outstanding when the mandate was approved, while utilising roughly 3.13% of the 144.29 million-share authorisation.</p>\n<p>All 4.52 million repurchased shares are awaiting cancellation; consequently, PW Medtech’s issued share capital remains unchanged at 1.43 billion shares as of 11 September 2026. Repurchase prices over the period have ranged from HKD 0.91 to HKD 1.10 per share.</p>\n<p>Under Hong Kong Stock Exchange rules, PW Medtech is subject to a 30-day moratorium on issuing new shares following the latest buy-back, ending on 11 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PW Medtech Logs Further Buy-Back; 4.52 Million Shares Repurchased to Date, Equal to 0.31% of Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPW Medtech Logs Further Buy-Back; 4.52 Million Shares Repurchased to Date, Equal to 0.31% of Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-11 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PW Medtech Group Limited disclosed in its latest Next Day Disclosure Return that it repurchased an additional 106,000 ordinary shares on 11 September 2026 via on-market transactions at HKD 0.97–0.975 per share, for a total consideration of HKD 0.10 million.</p>\n<p>Including this purchase, the company has acquired 4.52 million shares since activating its current repurchase mandate on 26 June 2026. The cumulative volume represents 0.31% of the 1.43 billion shares outstanding when the mandate was approved, while utilising roughly 3.13% of the 144.29 million-share authorisation.</p>\n<p>All 4.52 million repurchased shares are awaiting cancellation; consequently, PW Medtech’s issued share capital remains unchanged at 1.43 billion shares as of 11 September 2026. Repurchase prices over the period have ranged from HKD 0.91 to HKD 1.10 per share.</p>\n<p>Under Hong Kong Stock Exchange rules, PW Medtech is subject to a 30-day moratorium on issuing new shares following the latest buy-back, ending on 11 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01358","symbol_name":"普华和顺","start_time":0,"source_url":"","article_id":"1105675220","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105675220","pubTimestamp":1789125874,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PW Medtech Group Limited disclosed in its latest Next Day Disclosure Return that it repurchased an additional 106,000 ordinary shares on 11 September 2026 via on-market transactions at HKD 0.97–0.975...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01358":"普华和顺"},"translate_title":"PW Medtech 记录进一步回购；迄今为止已回购452万股，相当于股本的0.31%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01358":1},"content_text":"PW Medtech Group Limited disclosed in its latest Next Day Disclosure Return that it repurchased an additional 106,000 ordinary shares on 11 September 2026 via on-market transactions at HKD 0.97–0.975 per share, for a total consideration of HKD 0.10 million.\nIncluding this purchase, the company has acquired 4.52 million shares since activating its current repurchase mandate on 26 June 2026. The cumulative volume represents 0.31% of the 1.43 billion shares outstanding when the mandate was approved, while utilising roughly 3.13% of the 144.29 million-share authorisation.\nAll 4.52 million repurchased shares are awaiting cancellation; consequently, PW Medtech’s issued share capital remains unchanged at 1.43 billion shares as of 11 September 2026. Repurchase prices over the period have ranged from HKD 0.91 to HKD 1.10 per share.\nUnder Hong Kong Stock Exchange rules, PW Medtech is subject to a 30-day moratorium on issuing new shares following the latest buy-back, ending on 11 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}